CellVir
├ëvry · Founded 2006
About CellVir
CellVir, founded in March 2006, is developing a new generation of anti-retrovirals based on a novel therapeutic mode of action. Instead of targeting the inhibition of the catalytic activity of viral enzymes (as do most of today's drugs), CellVir's approach targets host-virus protein-protein interactions which have been shown to be essential for viral replication in infected cells. Drugs operating via this novel mode of action offer two key potential advantages: complementarity to existing drugs because of their lack of susceptibility to cross resistance mechanisms, and a reduced occurrence of viral mutations that lead to drug resistance.
Company Facts
- Founded: 2006
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $387.0K
- Last round: Series Unknown (Jun 2008)
- Website: cellvir.com
- Phone: [email protected]
Canonical: https://fsome.com/organization/cellvir-8463857 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.